Literature DB >> 18677155

Cognitive changes after menopause: influence of estrogen.

Victor W Henderson1.   

Abstract

The natural menopause is not associated with substantial cognitive change. Limited clinical trial evidence suggests that estrogen-containing hormone therapy has little effect on cognition during midlife, but prompt initiation after surgical menopause may improve aspects of memory. Among older postmenopausal women, strong clinical trial evidence demonstrates that hormone initiation does not improve cognition. More limited clinical trial evidence indicates no improvement in Alzheimer symptoms, and the Women's Health Initiative Memory Study found an increase in dementia risk among older women. Observational findings of reduced Alzheimer risk may reflect early hormone use in younger women, or findings may be biased. Cognitive effects of selective estrogen receptor modulators are not yet well studied.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677155      PMCID: PMC2637911          DOI: 10.1097/GRF.0b013e318180ba10

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  44 in total

1.  Effects of estrogen on memory function in surgically menopausal women.

Authors:  S M Phillips; B B Sherwin
Journal:  Psychoneuroendocrinology       Date:  1992-10       Impact factor: 4.905

2.  "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.

Authors:  B B Sherwin; T Tulandi
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

3.  Estrogen replacement therapy and risk of Alzheimer disease.

Authors:  A Paganini-Hill; V W Henderson
Journal:  Arch Intern Med       Date:  1996-10-28

4.  A longitudinal study of cognition change during early menopausal transition in a rural community.

Authors:  Jong-Ling Fuh; Shuu-Jiun Wang; Shin-Jung Lee; Shiang-Ru Lu; Kai-Dih Juang
Journal:  Maturitas       Date:  2005-09-27       Impact factor: 4.342

5.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

Authors:  M X Tang; D Jacobs; Y Stern; K Marder; P Schofield; B Gurland; H Andrews; R Mayeux
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

6.  Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study.

Authors:  D E Brenner; W A Kukull; A Stergachis; G van Belle; J D Bowen; W C McCormick; L Teri; E B Larson
Journal:  Am J Epidemiol       Date:  1994-08-01       Impact factor: 4.897

7.  Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.

Authors:  Jae H Kang; Jennifer Weuve; Francine Grodstein
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

8.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Stephen R Rapp; Mark A Espeland; Sally A Shumaker; Victor W Henderson; Robert L Brunner; JoAnn E Manson; Margery L S Gass; Marcia L Stefanick; Dorothy S Lane; Jennifer Hays; Karen C Johnson; Laura H Coker; Maggie Dailey; Deborah Bowen
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

10.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Mark A Espeland; Stephen R Rapp; Sally A Shumaker; Robert Brunner; JoAnn E Manson; Barbara B Sherwin; Judith Hsia; Karen L Margolis; Patricia E Hogan; Robert Wallace; Maggie Dailey; Ruth Freeman; Jennifer Hays
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

View more
  40 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

2.  Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.

Authors:  Shanna L Burke; Tianyan Hu; Nicole M Fava; Tan Li; Miriam J Rodriguez; Katie L Schuldiner; Aaron Burgess; Angela Laird
Journal:  J Women Aging       Date:  2018-01-10

Review 3.  Role of progesterone in nicotine addiction: evidence from initiation to relapse.

Authors:  Wendy J Lynch; Mehmet Sofuoglu
Journal:  Exp Clin Psychopharmacol       Date:  2010-12       Impact factor: 3.157

4.  Effects of synaptic plasticity regulated by 17beta-estradiol on learning and memory in rats with Alzheimer's disease.

Authors:  Xiu-Li Shang; Jiu-Han Zhao; Yun-Peng Cao; Yi-Xue Xue
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

5.  [Validity and Reliability of the Korean Version of the Menopause-Specific Quality of Life].

Authors:  Jin Hee Park; Sun Hyoung Bae; Young Mi Jung
Journal:  J Korean Acad Nurs       Date:  2020-06       Impact factor: 0.984

6.  Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers.

Authors:  Mehmet Sofuoglu; Maria Mouratidis; Marc Mooney
Journal:  Psychoneuroendocrinology       Date:  2010-08-02       Impact factor: 4.905

7.  Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation.

Authors:  Quan-Guang Zhang; Limor Raz; Ruimin Wang; Dong Han; Liesl De Sevilla; Fang Yang; Ratna K Vadlamudi; Darrell W Brann
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

8.  Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women.

Authors:  Chitra Lal; Michelle M DiBartolo; Suchit Kumbhare; Charlie Strange; Jane E Joseph
Journal:  Sleep Breath       Date:  2015-09-18       Impact factor: 2.816

9.  Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.

Authors:  Whitney Wharton; Carey E Gleason; Katelin R Lorenze; Tamara S Markgraf; Michele L Ries; Cynthia M Carlsson; Sanjay Asthana
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

10.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.